Indivior Pharmaceuticals, Inc. INDV Accrued Rebates, Returns, and Promotions
Accrued Rebates, Returns, and Promotions at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerRefundLiabilityCurrent.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's accrued rebates, returns, and promotions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's accrued rebates, returns, and promotions?
- Indivior Pharmaceuticals, Inc. (INDV) reported accrued rebates, returns, and promotions of $551M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's accrued rebates, returns, and promotions changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's accrued rebates, returns, and promotions decreased by 18.4% year-over-year, from $675M to $551M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's accrued rebates, returns, and promotions?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's accrued rebates, returns, and promotions has grown at a 4.3% compound annual growth rate (CAGR), from $535M to $582M.
- What does accrued rebates, returns, and promotions mean?
- This represents the estimated financial liability for expected customer rebates, product returns, and various promotional incentives offered to distributors or healthcare providers. It reflects the company's obligation to provide future credits or payments based on historical sales activity and contractual agreements. Monitoring this balance is essential for assessing the accuracy of revenue recognition and the potential impact of future sales adjustments on cash flow.